NCT05470595 2025-12-30LCNEC-ALPINETechnische Universität DresdenPhase 2 Active not recruiting67 enrolled
NCT03728361 2025-12-18Nivolumab and Temozolomide in Treating Patients With Recurrent or Refractory Small-Cell Lung Cancer or Advanced Neuroendocrine CancerOhio State University Comprehensive Cancer CenterPhase 2 Active not recruiting55 enrolled
NCT04701307 2025-12-15Niraparib and Dostarlimab for the Treatment of Small Cell Lung Cancer and Other High-Grade Neuroendocrine CarcinomasM.D. Anderson Cancer CenterPhase 2 Active not recruiting48 enrolled
NCT02489903 2025-03-17RRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT)EpicentRx, Inc.Phase 2 Completed139 enrolled 14 charts
NCT00019331 2013-06-20Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid TumorsNational Cancer Institute (NCI)Phase 2 Completed
NCT00027638 2013-06-18Thalidomide in Treating Patients With Metastatic Neuroendocrine TumorsMemorial Sloan Kettering Cancer CenterPhase 2 Completed